Hydralazine Hydrochloride Tablet
Product Images NDC 70518-3852

2 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydralazine Hydrochloride (NDC 70518-3852). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Structure (Image 01)

Chem Structure (Image 01)
Chemical structure of hydralazine hydrochloride, showing a bicyclic ring system with attached hydrazine and hydrochloride components.*
FDA Label Image

Mm1 (Hydralazine HCl 25mg 70518 3852 00)

Mm1 (Hydralazine HCl 25mg 70518 3852 00)
Hydralazine Hydrochloride 25 mg oral tablet packaging label showing a quantity of 30 tablets. Label includes the NDC number 70518-3852-00 and is repackaged by RemedyRepack Inc., Indiana, PA. The manufacturing NDC and manufacturer ScieGen, Hauppauge, NY are also noted, along with storage instructions and a QR code.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.